Papadimitriou Menelaos

PRESERFLO™ MicroShunt as a treatment option for highly increased intraocular pressure in primary open angle glaucoma and pseudoexfoliation glaucoma.

PF appears to be a suitable option for managing both highly and moderately increased IOP levels in POAG and PXG eyes, with comparable outcomes up to 12 months following surgery.

Results of open bleb revision as management of primary bleb failure following XEN 45 gel stent and Preserflo™ Microshunt.

Although OBR was effective as management of PBF following XEN and PF, SR were higher after XEN than after PF along with comparable safety profile.